Sensei Biotherapeutics to Present at Citi 14th Annual Biotech Conference
GAITHERSBURG, Md.–(BUSINESS WIRE)–Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced that John Celebi, President and Chief Executive Officer of Sensei Biotherapeutics, will participate in a private company panel discussion at the Citi 14th …